Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Are you more likely to recommend radiation over omission? Whole breast over APBI?
Answer from: Radiation Oncologist at Community Practice
It doesn’t change the recommendation. If adequate, imaging and surgery are done, like any other DCIS.
Sign In
or
Register
to read more
28151
Related Questions
Do you omit PMRT for patients who would have been eligible for NSABP B-51, but are found to have significant pure LVSI only, without stromal carcinoma, after neoadjuvant chemotherapy?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?
In which patients do you utilize a breast MRI as part of the initial workup for breast cancer?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
What is your preferred comprehensive nodal irradiation approach in non-metastatic breast cancer patients with underlying respiratory diseases or poor baseline respiratory function in light of the findings from the RadComp Trial?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
How would you treat a schwannoma of the breast with a positive margin that is not amenable to re-excision?